2-(4-乙酰胺基苯基)噻唑烷-4-羧酸 | 849052-66-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(4-乙酰胺基苯基)噻唑烷-4-羧酸
• 英文名称: (2RS,4R)-2-(4-acetylaminophenyl)-thiazolidine-4-carboxylic acid
• 英文别名: (4R)-2-(4-Acetamidophenyl)thiazolidine-4-carboxylic acid；(4R)-2-(4-acetamidophenyl)-1,3-thiazolidine-4-carboxylic acid
• CAS: 849052-66-0
• 化学式: C₁₂H₁₄N₂O₃S
• mdl: MFCD13244373
• 分子量: 266.321
• InChiKey: UCWVNLWPXJNEEK-VUWPPUDQSA-N

物化性质

• 沸点：
  589.6±50.0 °C(Predicted)
• 密度：
  1.374±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.6
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  104
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-(4-乙酰胺基苯基)噻唑烷-4-羧酸 在 sodium hydroxide 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 、 三氟乙酸 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 生成 (4R)-2-(4-acetylamino-phenyl)-thiazolidine-4-carboxylic acid hexadecylamide
  参考文献：
  名称：

  Synthesis and antiproliferative activity of thiazolidine analogs for melanoma

  摘要：

  We have previously described 2-aryl-thiazolidine-4-carboxylic acid amides as a novel class of antiproliferative agents for prostate cancer. Screening these compounds with melanoma cell lines revealed that several of them have potent antiproliferative activity and selectivity against melanoma. To further improve the potency and selectivity, we synthesized a new series of analogs and tested them in two melanoma cell lines and fibroblast cells (negative controls). Comparison of anticancer effects of these compounds with a standard chemotherapeutic agent, sorafenib, showed that they are very effective in killing melanoma cells with low micromolar to nanomolar antiproliferative activity and provide us a new lead for developing potential drugs for melanoma. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.05.059
• 作为产物：
  描述：

  L-半胱氨酸 、 对乙酰氨基苯甲醛 以 乙醇 、 水 为溶剂， 生成 2-(4-乙酰胺基苯基)噻唑烷-4-羧酸
  参考文献：
  名称：

  抗癌药物2-芳基噻唑烷-4-甲酰胺的合成、体外构效关系及体内研究

  摘要：

  合成了一系列(2RS , 4R ) -2-芳基噻唑烷-4-甲酰胺(ATCAA)。与对照细胞（分别为成纤维细胞和 RH7777）相比，评估了针对黑色素瘤和前列腺癌细胞的抗增殖活性。化合物3id对三种黑色素瘤细胞系（B16-F1、A375 和 WM-164）表现出最佳的选择性和生长抑制活性。化合物15b和3ac对四种前列腺癌细胞系（DU 145、PC-3、LNCaP 和 PPC-1）具有良好的选择性和效力。讨论了侧链、噻唑烷环和苯基取代基的构效关系（SAR）。细胞周期分析表明，用1b和3ad处理后，发生凋亡（亚 G1 期）的癌细胞百分比增加，这也强烈抑制了黑色素瘤集落的形成。对带有 A375 黑色素瘤肿瘤的裸鼠的体内研究表明，化合物1b以剂量依赖性方式抑制肿瘤生长。在 10 mg/kg 的剂量下，1b显着抑制黑色素瘤肿瘤的生长，并且比 60 mg/kg 的达卡巴嗪显示出更高的疗效。

  DOI：

  10.1016/j.bmc.2009.12.020

文献信息

• Synthesis and antihypertensive activity of N-(mercaptoacyl)-thiazolidinecarboxylic acids.
  作者：MASAYUKI OYA、TOSHIO BABA、EISHIN KATO、YOICHI KAWASHIMA、TOSHIO WATANABE

  DOI：10.1248/cpb.30.440

  日期：——

  The synthesis and antihypertensive activity of a new series of N-(mercaptoacyl)-thiazolidinecarboxylic acids (VIIa-d) are described. Antihypertensive activity was evaluated in terms of angiotensin I-converting enzyme (ACE) inhibitory activity. The activities of these compounds were compared with that of (2S)-1-[(2S)-3-mercapto-2-methylpropanoyl] proline, SQ 14225, and many of them were found to be relatively potent inhibitors of ACE. The most potent was (4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropanoyl)-4-thiazolidinecarboxylic acid (62). Structure-activity relationships among the thiazolidines and some related compounds are discussed.

  报道了一系列新型N-(巯基乙酰基)-噻唑烷羧酸(VIIa-d)的合成及其抗高血压活性。抗高血压活性通过血管紧张素I转化酶(ACE)抑制活性来评估。这些化合物的活性与(2S)-1-[(2S)-3-巯基-2-甲基丙酰基]脯氨酸(SQ 14225)进行了比较，发现其中许多化合物是相对强效的ACE抑制剂。其中最有效的是(4R)-2-(2-羟基苯基)-3-(3-巯基丙酰基)-4-噻唑烷羧酸(62)。讨论了噻唑烷及其相关化合物的结构-活性关系。
• Discovery of 2-Arylthiazolidine-4-carboxylic Acid Amides as a New Class of Cytotoxic Agents for Prostate Cancer
  作者：Veeresa Gududuru、Eunju Hurh、James T. Dalton、Duane D. Miller

  DOI：10.1021/jm049208b

  日期：2005.4.1

  To improve the selectivity and antiproliferative activity of previously reported serine amide phosphates (SAPs), we designed a new series of 4-thiazolidinone amides, in which the 4-thiazolidinone moiety was introduced as a phosphate mimic. However, these 4-thiazolidinone derivatives demonstrated less cytotoxicity in prostate cancer cells despite improved selectivity over RH7777 cells. To further optimize the thiazolidinone analogues in terms of cytotoxicity and selectivity, we made closely related structural modifications, which led us to the discovery of a new class of 2-arylthiazolidine-4-carboxylic acid amides. These compounds were potent cytotoxic agents with IC50 values in the low micromolar concentration range and demonstrated enhanced selectivity in receptor-negative cells compared to SAPs and 4-thiazolidinone amides.
• Gyoergydeak, Zoltan; Kajtar-Peredy, Maria; Kajtar, Judit, Liebigs Annalen der Chemie, 1987, p. 927 - 934
  作者：Gyoergydeak, Zoltan、Kajtar-Peredy, Maria、Kajtar, Judit、Kajtar, Marton

  DOI：——

  日期：——
• OYA, MASAYUKI;BABA, TOSHIO;KATO, EISHIN;KAWASHIMA, YOICHI;WATANABE, TOSHI+, CHEM. AND PHARM. BULL., 1982, 30, N 2, 440-461
  作者：OYA, MASAYUKI、BABA, TOSHIO、KATO, EISHIN、KAWASHIMA, YOICHI、WATANABE, TOSHI+

  DOI：——

  日期：——
• GYORGYDEAK, ZOLTAN;KAJTAR-PEREDY, MARIA;KAJTAR, JUDIT;KAJTAR, MARTON, LIEBIGS ANN. CHEM.,(1987) N 11, 924-934
  作者：GYORGYDEAK, ZOLTAN、KAJTAR-PEREDY, MARIA、KAJTAR, JUDIT、KAJTAR, MARTON

  DOI：——

  日期：——